Investigating how a peptide affects aging-related dementia

Understanding vascular aging-related dementia through medin signaling

NIH-funded research Arizona Veterans Research and Education Foundation · NIH-10901026

This study is looking at how a substance called medin, which builds up in our blood vessels as we get older, might be linked to dementia, like Alzheimer's, and aims to find ways to reduce its harmful effects on the brain and blood vessels.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionArizona Veterans Research and Education Foundation NIH-funded
Lab location1 site (Phoenix, United States)
Project IDNIH-10901026 on NIH RePORTER

What this research studies

This research explores the relationship between vascular aging and dementia, particularly focusing on a peptide called medin that accumulates in blood vessels as we age. The study aims to understand how medin contributes to cell and tissue damage, which may lead to conditions like Alzheimer's disease. Using advanced genetic screening techniques, researchers will identify the biological pathways involved in medin toxicity and test potential treatments to reverse its harmful effects. Additionally, they will create a mouse model to study the impact of medin on brain and vascular health.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults who are at risk for or have been diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with non-vascular forms of dementia or those who are not elderly may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that mitigate the effects of aging on vascular health and reduce the risk of dementia.

How similar studies have performed: While the specific approach of targeting medin is novel, similar studies have shown promise in understanding the links between vascular health and dementia.

Where this research is happening

Phoenix, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.